SEC
Filings

Menu

Tabs Financials

SEC Filings

Filing date Form Description Filing Group View
10-K

Annual report which provides a comprehensive overview of the company for the past year

Annual Filings
View HTML EX-101.INS - XBRL INSTANCE DOCUMENT
10-K

Annual report which provides a comprehensive overview of the company for the past year

Annual Filings
View HTML EX-101.INS - XBRL INSTANCE DOCUMENT
10-K

Annual report which provides a comprehensive overview of the company for the past year

Annual Filings
View HTML EX-101.INS - XBRL INSTANCE DOCUMENT
10-K

Annual report which provides a comprehensive overview of the company for the past year

Annual Filings
View HTML EX-101.INS - XBRL INSTANCE DOCUMENT
10-K

Annual report which provides a comprehensive overview of the company for the past year

Annual Filings
View HTML EX-101.INS - XBRL INSTANCE DOCUMENT
10-K

Annual report which provides a comprehensive overview of the company for the past year

Annual Filings
View HTML EX-101.INS - XBRL INSTANCE DOCUMENT
10-K

Annual report which provides a comprehensive overview of the company for the past year

Annual Filings
View HTML EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
10-K

Annual report which provides a comprehensive overview of the company for the past year

Annual Filings
View HTML EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
10-K

Annual report which provides a comprehensive overview of the company for the past year

Annual Filings
View HTML EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
10-K/A

Amendment to a previously filed 10-K

Annual Filings
View HTML

Data provided by Kaleidoscope.

 

Investor Contact

Richard Eisenstadt
Chief Financial Officer

Email: reisenstadt@altimmune.com

 

Email Alerts

Automatically receive Altimmune, Inc. financial information by e-mail

Subscribe